首页> 外国专利> Novel polymorphisms in ABCB1 in the context of lack of clinical response to drugs

Novel polymorphisms in ABCB1 in the context of lack of clinical response to drugs

机译:在缺乏对药物的临床反应的背景下,ABCB1中的新型多态性

摘要

The present invention relates to methods, compositions, kits and reagents for determining the prognosis of a clinical response in a human patient to a medicament which acts in the central nervous system (CNS) and which is a substrate of the ABCB1 protein. Further, the invention relates to a combination of medicaments for the treatment of human patients having specific polymorphisms in the ABCB1 gene.
机译:本发明涉及用于确定人类患者对在中枢神经系统(CNS)中起作用并且是ABCB1蛋白底物的药物的临床反应的预后的方法,组合物,试剂盒和试剂。此外,本发明涉及用于治疗在ABCB1基因中具有特定多态性的人类患者的药物组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号